wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55514103-2A178E1C-FC8E-4DB8-99FC-8E58F2612F6E
Q55514103-2A178E1C-FC8E-4DB8-99FC-8E58F2612F6E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55514103-2A178E1C-FC8E-4DB8-99FC-8E58F2612F6E
Can the Ceftriaxone Breakpoints Be Increased Without Compromising Patient Outcomes?
P2860
Q55514103-2A178E1C-FC8E-4DB8-99FC-8E58F2612F6E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55514103-2A178E1C-FC8E-4DB8-99FC-8E58F2612F6E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bb38750f1c96ed04ae4f19caced2b6c5a3914055
P2860
Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam.